表紙
市場調查報告書

皮膚微生物調節的全球市場 (2019-2030年)

Global Skin Microbiome Modulators Market: Focus on Products, Applications, Distribution Channels, Country Data (14 Countries), and Competitive Landscape - Analysis and Forecast, 2019-2030

出版商 BIS Research Inc. 商品編碼 949760
出版日期 內容資訊 英文 200 Pages
商品交期: 最快1-2個工作天內
價格
皮膚微生物調節的全球市場 (2019-2030年) Global Skin Microbiome Modulators Market: Focus on Products, Applications, Distribution Channels, Country Data (14 Countries), and Competitive Landscape - Analysis and Forecast, 2019-2030
出版日期: 2020年07月13日內容資訊: 英文 200 Pages
簡介

全球皮膚微生物調節的市場預計2030年成長到29億7000萬美元的規模

本報告提供全球皮膚微生物調節的市場調查,市場定義概要,市場成長的各種影響因素分析,相關法律,市場規模的變化、預測,產品類型、用途、通路、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等資訊彙整。

第1章 產品定義

第2章 市場範圍

第3章 調查手法

第4章 市場概要

  • 市場定義
  • 人體微生物計劃
  • 市場規模、成長可能性
  • 未來的潛在性
  • COVID-19的影響

第5章 產業分析

  • 概要
  • 法律上的必要條件、架構:美國
  • 法律上的必要條件、架構:歐洲
  • 法律上的必要條件、架構:亞太地區
  • 資金籌措方案
  • 專利分析
  • 全球微生物聯盟

第6章 市場動態

  • 概要
  • 影響分析
  • 推動成長因素
  • 阻礙成長要素
  • 市場機會

第7章 競爭情形

  • 協同效應的配合措施
  • 事業擴大的配合措施
  • 產品的銷售、產品的更新
  • M&A
  • 市場佔有率分析
  • 開發平台分析

第8章 市場分析、預測:各產品類型

  • 概要
  • 益生菌
  • 益生元
  • 藥物

第9章 市場分析、預測:各用途

  • 概要
  • 護膚
  • 護髮
  • 其他

第10章 市場分析、預測:各銷售管道

  • 概要
  • 線上途徑
  • 大賣場、超級市場
  • 直銷
  • 專賣店
  • 藥妝店

第11章 市場分析、預測:各地區、主要國家

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 其他地區

第12章 企業簡介

  • AOBiome
  • Azitra, Inc.
  • Colgate-Palmolive Company
  • Evelo Biosciences, Inc.
  • GALLINEE
  • Glowbiotics, Inc.
  • Johnson & Johnson Services, Inc.
  • L'Oreal S.A.
  • MATRISYS BIOSCIENCE
  • Quorum Innovations
  • Revlon
  • Siolta Therapeutics
  • The Estee Lauder Companies Inc.
  • TULA Life, INC
  • Unilever
  • Yakult Honsha Co., Ltd
目錄
Product Code: BHP0911SA

"Global Skin Microbiome Modulators Market to Reach $2.97 Billion by 2030."

Market Segmentation

  • By Product Type: Probiotics, Prebiotics, and Drugs
  • By Application: Skin Care, Hair Care, and Other Applications
  • By Distribution Channels: Online Channels, Hypermarkets and Supermarkets, Direct Selling, Specialty Stores, Drug Stores
  • By Region: North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World

Regional Segmentation

  • North America: U.S. and Canada
  • Europe: Germany, France, U.K., Italy, Spain, and Rest-of-Europe
  • Asia-Pacific: Japan, China, India, South Korea, Australia, and Rest-of-Asia-Pacific
  • Latin America: Brazil, Mexico, and Rest-of-Latin America
  • Rest-of-the-World

Growth Drivers

  • Increasing Emphasis on Microbiome's Potential for Human Health
  • Increasing Entry of Legacy Cosmetic Companies into Skin Microbiome Modulators Industry
  • Decreasing Cost of Sequencing

Market Challenges

  • Non-Standardization of Claims and Stringent Regulatory Standards
  • Lack of Knowledge on Probiotic-based Products
  • Cost of the Cosmetic Products-based on Probiotics

Market Opportunities

  • Investiture of Next Generation Probiotics for Enhancement of Probiotic Drugs
  • Growing Integrative Industry-Academia Collaboration
  • Pipeline Drugs Anticipated Future Potential to The Skin Microbiome Modulators Market

Key Companies Profiled

AOBiome, Azitra, Inc., Colgate-Palmolive Company, Evelo Biosciences Inc., GALLINEE , Glowbiotics,Inc., Johnson & Johnson Services, Inc., L'Oreal S.A.,MATRYSIS BIOSCIENCE, Quorum Innovations, Revlon, Siolta Therapeutics, The Estee Lauder Companies , Inc., TULA Life Inc., Unilever , and Yakult Honsha Co. Ltd.

Key Questions Answered in this Report:

  • What are the major market drivers, challenges, and opportunities, and their respective impacts in the global skin microbiome modulators market?
  • What are the key development strategies which are implemented by the major players in order to sustain in the competitive market?
  • What are the key regulatory hurdles while defining products as cosmetics or food or therapeutics being faced by the industry players?
  • What are the key takeaways from the highly dynamic funding scenario in the skin microbiome modulators market?
  • What are the key microorganism formulations being patented for emerging application areas?
  • Which is the dominant product type developed by the leading and emerging players for the global skin microbiome modulators market?
  • What are the key probiotic strains being employed for product formulation in the skin microbiome modulators market?
  • How will the commercialization of drugs or medical probiotics impact the market scenario?
  • What are the key technologies that have been used by leading players in the global skin microbiome modulators market?
  • How each segment of the market is expected to grow during the forecast period from 2020 to 2030 based on:
    • product type
    • application
    • distribution channel
    • region
  • Which companies are anticipated to be highly disruptive in the future, and why?
  • What are the key application areas for skin microbiome modulators in 2020, and which application areas are expected to witness growth in the forecast period?

Market Overview

The skin microbiome has been an exciting area of research, significantly expanding applications beyond the gut microbiome. The use of probiotics in skin creams has been an area of research for over a decade now. As further understanding enables comprehension of the function of the skin microbiome and how it can be modulated to address diseases, such as acne, eczema, and rosacea, the global cosmetics industry is investing tremendously in the space. In addition, the landscape is also teeming with a large number of start-ups that have already entered the market with commercialized products. However, a major revelation would definitely come in the form of drugs that are currently being developed based on modulating the skin microbiome.

The current skin microbiome modulators market is mainly dominated by several cosmetic majors, such as Colgate-Palmolive Company, Johnson & Johnson Services, Inc., L'Oreal S.A., TULA Life Inc., Unilever, and Yakult Honsha Co. Ltd. which offer a wide variety of probiotics and prebiotics products for skin care and hair care applications.

The existing market of skin microbiome modulators is favored by multiple factors, which include a global emphasis on the microbiome's potential for human health. In addition, entry of legacy cosmetic companies into the skin microbiome modulators industry to the global skin microbiome modulators market will provide a lucrative growth for this market.

Within the research report, the market is segmented on the basis of product type, application, distribution channels, and region, which highlight value propositions and business models useful for industry leaders and stakeholders. The research also comprises country-level analysis, go-to-market strategies of leading players, future opportunities, among others, to detail the scope and provide 360-degree coverage of the domain.

Competitive Landscape

Major players, Colgate-Palmolive Company, Johnson & Johnson Services, Inc., L'Oreal S.A., TULA Life Inc., Unilever, and Yakult Honsha Co. Ltd. including among others, led the number of key developments witnessed by the market. On the basis of region, North America is expected to retain a leading position throughout the forecast period 2020-2030, followed by Europe. This is a result of the presence of leading industry players in this region, coupled up with the millennial population growth.

Table of Contents

1 Product Definition

  • 1.1 Inclusion and Exclusion

2 Market Scope

  • 2.1 Scope of Work
  • 2.2 Key Questions Answered in the Report

3 Research Methodology

  • 3.1 Global Skin Microbiome Modulators Market: Research Methodology
  • 3.2 Primary Data Sources
  • 3.3 Secondary Data Sources
  • 3.4 Market Estimation Model
  • 3.5 Criteria for Company Profiling

4 Market Overview

  • 4.1 Market Definition
  • 4.2 The Human Microbiome Project: 2007-2016
  • 4.3 Market Size and Growth Potential, $Million, 2019-2030
  • 4.4 Future Potential
  • 4.5 COVID-19 Impact on the Global Skin Microbiome Modulators Market

5 Industry Insights

  • 5.1 Overview
  • 5.2 Legal Requirements and Framework in the U.S.
  • 5.3 Legal Requirements and Framework in Europe
  • 5.4 Legal Requirements and Framework in Asia-Pacific
    • 5.4.1 China
  • 5.5 Funding Scenario
  • 5.6 Patent Analysis
    • 5.6.1 Overview
    • 5.6.2 Patent Classification
    • 5.6.3 Regional Analysis
    • 5.6.4 Microorganism Analysis
    • 5.6.5 Key Highlights
  • 5.7 Global Microbiome Consortiums

6 Market Dynamics

  • 6.1 Overview
  • 6.2 Impact Analysis
  • 6.3 Market Drivers
    • 6.3.1 Increasing Emphasis on Microbiome's Potential for Human Health
    • 6.3.2 Increasing Entry of Legacy Cosmetic Companies into Skin Microbiome Modulators Industry
    • 6.3.3 Decreasing Cost of Sequencing
  • 6.4 Market Restrains
    • 6.4.1 Non-Standardization of Claims and Stringent Regulatory Standards
    • 6.4.2 Lack of Knowledge on Probiotic-Based Products
    • 6.4.3 Cost of the Cosmetic Products-Based on Probiotics
  • 6.5 Market Opportunities
    • 6.5.1 Investiture of Next-Generation Probiotics for Enhancement of Probiotic Drugs
    • 6.5.2 Growing Integrative Industry-Academia Collaboration
    • 6.5.3 Pipeline Drugs Anticipated Future Potential to the Skin Microbiome Modulators Market

7 Competitive Landscape

  • 7.1 Synergistic Activities
  • 7.2 Business Expansion Activities and Others
  • 7.3 Product Launches and Product Updates
  • 7.4 Mergers and Acquisitions
  • 7.5 Market Share Analysis, 2018-2019
  • 7.6 Growth Share Analysis
    • 7.6.1 Growth Share Analysis (by Company)
    • 7.6.2 Growth Share Analysis (by Application)
    • 7.6.3 Growth Share Analysis (by Country)
  • 7.7 Pipeline Analysis (2017-2019)

8 Global Skin Microbiome Modulators Market (by Product Type)

  • 8.1 Overview
  • 8.2 Probiotics
  • 8.3 Prebiotics
  • 8.4 Drugs

9 Global Skin Microbiome Modulators Market, (by Application)

  • 9.1 Overview
  • 9.2 Skin Care
  • 9.3 Hair Care
  • 9.4 Other Applications

10 Global Skin Modulators Market (by Distribution Channels)

  • 10.1 Overview
  • 10.2 Online Channels
  • 10.3 Hypermarkets and Supermarkets
  • 10.4 Direct Selling
  • 10.5 Specialty Store
  • 10.6 Drug Stores

11 Global Skin Microbiome Modulators Market (by Region)

  • 11.1 Overview
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 France
    • 11.3.3 U.K.
    • 11.3.4 Italy
    • 11.3.5 Spain
    • 11.3.6 Rest-of-Europe
  • 11.4 Asia-Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 South Korea
    • 11.4.3 Australia
    • 11.4.4 India
    • 11.4.5 Rest-of-APAC
  • 11.5 Latin America
    • 11.5.1 Brazil
    • 11.5.2 Mexico
    • 11.5.3 Rest-of-Latin America
  • 11.6 Rest-of-the-World

12 Company Profiles

  • 12.1 Overview
  • 12.2 AOBiome
    • 12.2.1 Company Overview
    • 12.2.2 Role of AOBiome in the Global Skin Microbiome Modulators Market
    • 12.2.3 SWOT Analysis
  • 12.3 Azitra, Inc.
    • 12.3.1 Company Overview
    • 12.3.2 Role of Azitra, Inc. in the in the Global Skin Microbiome Modulators Market
    • 12.3.3 SWOT Analysis
  • 12.4 Colgate-Palmolive Company
    • 12.4.1 Company Overview
    • 12.4.2 Role of Colgate-Palmolive in the Global Skin Microbiome Modulators Market
    • 12.4.3 Financials
    • 12.4.4 SWOT Analysis
  • 12.5 Evelo Biosciences, Inc.
    • 12.5.1 Company Overview
    • 12.5.2 Role of Evelo Biosciences, Inc. in the Global Skin Microbiome Modulators Market
    • 12.5.3 SWOT Analysis
  • 12.6 GALLINEE
    • 12.6.1 Company Overview
    • 12.6.2 Role of GALLINEE in the Global Skin Microbiome Modulators Market
    • 12.6.3 SWOT Analysis
  • 12.7 Glowbiotics, Inc.
    • 12.7.1 Company Overview
    • 12.7.2 Role of Glowbiotics, Inc. in the Global Skin Microbiome Modulators Market
    • 12.7.3 SWOT Analysis
  • 12.8 Johnson & Johnson Services, Inc.
    • 12.8.1 Company Overview
    • 12.8.2 Role of Johnson & Johnson in the Global Skin Microbiome Modulators Market
    • 12.8.3 Financials
    • 12.8.4 Key Insights about Financial Health of the Company
    • 12.8.5 SWOT Analysis
  • 12.9 L'Oreal S.A.
    • 12.9.1 Company Overview
    • 12.9.2 Role of L'Oreal S.A in the Global Skin Microbiome Modulators Market
    • 12.9.3 Financials
    • 12.9.4 SWOT Analysis
  • 12.1 MATRISYS BIOSCIENCE
    • 12.10.1 Company Overview
    • 12.10.2 Role of MATRISYS BIOSCINCE in the Global Skin Microbiome Modulators Market
    • 12.10.3 SWOT Analysis
  • 12.11 Quorum Innovations
    • 12.11.1 Company Overview
    • 12.11.2 Role of Quorum Innovations in the Global Skin Microbiome Modulators Market
    • 12.11.3 SWOT Analysis
  • 12.12 Revlon
    • 12.12.1 Role of Revlon in the Global Skin Microbiome Modulators Market
    • 12.12.2 Financials
    • 12.12.3 Key Insights About Financial Health of the Company
    • 12.12.4 SWOT Analysis
  • 12.13 Siolta Therapeutics
    • 12.13.1 Company Overview
    • 12.13.2 Role of Siolta Therapeutics in the Global Skin Microbiome Modulators Market
    • 12.13.3 SWOT Analysis
  • 12.14 The Estee Lauder Companies Inc.
    • 12.14.1 Company Overview
    • 12.14.2 Role of The Estee Lauder Companies, Inc. in the Global Skin Microbiome Modulators Market
    • 12.14.3 SWOT Analysis
  • 12.15 TULA Life, INC
    • 12.15.1 Company Overview
    • 12.15.2 Role of TULA Life, INC in the Global Skin Microbiome Modulators Market
    • 12.15.3 SWOT Analysis
  • 12.16 Unilever
    • 12.16.1 Company Overview
    • 12.16.2 Role of Unilever in the Global Skin Microbiome Modulators Market
    • 12.16.3 Financials
    • 12.16.4 SWOT Analysis
  • 12.17 Yakult Honsha Co., Ltd
    • 12.17.1 Company Overview
    • 12.17.2 Role of Yakult Honsha Co., Ltd. in the Global Skin Microbiome Modulators Market
    • 12.17.3 Financials
    • 12.17.4 SWOT Analysis

List of Tables

  • Table 5.1: Global Microbiome Consortiums and Their Participants
  • Table 6.1: Pipeline Drugs in the Skin Microbiome Modulators Market
  • Table 8.1: Examples of Probiotics in the Global Skin Microbiome Modulators Market
  • Table 8.2: Examples of Prebiotics in Global Skin Microbiome Modulators Market

List of Figures

  • Figure 1: Impact Analysis of Market Drivers and Market Challenges on the Global Skin Microbiome Modulators Market
  • Figure 2: Global Skin Microbiome Modulators Market (by Product), 2019 vs. 2030 ($Million)
  • Figure 3: Global Skin Microbiome Modulators Market (by Application), 2019 vs. 2030 ($Million)
  • Figure 4: Global Skin Microbiome Modulators Market (by Distribution Channel), 2019 vs. 2030 ($Million)
  • Figure 5: Global Skin Microbiome Modulators Market Snapshot
  • Figure 2.1: Global Skin Microbiome Modulators Market Segmentation
  • Figure 3.1: Global Skin Microbiome Modulators Market Research Methodology
  • Figure 3.2: Primary Research Methodology
  • Figure 3.3: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 3.4: Top-Down Approach (Segment-Wise Analysis)
  • Figure 4.1: Human Microbiota Sites
  • Figure 4.2: Significant Milestones from the Human Microbiome Project (Phase 1)
  • Figure 4.3: Global Skin Microbiome Modulators Market, 2019-2030
  • Figure 4.4: Global Skin Microbiome Modulators Market: COVID-19 Impact
  • Figure 5.1: Funding in Microbiome Projects (FY2012-FY2016)
  • Figure 5.2: Specific Microbial Members/Microbial Products Investigated in Microbiome Projects
  • Figure 6.1: Impact Analysis
  • Figure 6.2: Annual NIH Funding in the Human Microbiome Research, FY2007-FY2016
  • Figure 6.3: Decreasing Cost and Increasing Output (TB) of Genome Sequencing (2009-2025)
  • Figure 7.1: Share of Key Developments and Strategies, January 2017-June 2020
  • Figure 7.2: Synergistic Activities Share (by Company), January 2017-February 2020
  • Figure 7.3: Business Expansion Activities Share (by Company), January 2017- June 2020
  • Figure 7.4: Number of Product Launches (by Company), January 2017-June 2020
  • Figure 7.5: Market Share Analysis for Global Skin Microbiome Modulators Market, 2018 and 2019
  • Figure 7.6: Growth Share Analysis for Global Skin Microbiome Modulators Market (by Company), 2019
  • Figure 7.7: Growth Share Analysis for Global Skin Microbiome Modulators Market (by Application), 2019-2030
  • Figure 7.8: Growth Share Analysis for Global Skin Microbiome Modulators Market (by Country), 2019-2030
  • Figure 8.1: Global Skin Microbiome Modulators Market (by Product Type)
  • Figure 8.2: Global Skin Microbiome Modulators Market (by Product Type), 2019 and 2030
  • Figure 8.3: Global Skin Microbiome Modulators Market (by Probiotics), 2019-2030
  • Figure 8.4: Global Skin Microbiome Modulators Market (by Probiotic Microbes), 2019 and 2030
  • Figure 8.5: Global Skin Microbiome Modulators Market (by Bacterial Probiotics), 2019 and 2030
  • Figure 8.6: Global Skin Microbiome Modulators Market (by Prebiotics), 2019-2030
  • Figure 8.7: Global Skin Microbiome Modulators Market (by Drugs), 2019-2030
  • Figure 9.1: Global Skin Microbiome Modulators Market (by Application)
  • Figure 9.2: Global Skin Microbiome Modulators Market (by Application), 2019-2030
  • Figure 9.3: Global Skin Microbiome Modulators Market (by Skin Care), 2019-2030
  • Figure 9.4: Global Skin Microbiome Modulators Market (by Skin Care Applications), 2019 and 2030
  • Figure 9.5: Global Skin Microbiome Modulators Market (by Skin Care), 2019-2030
  • Figure 9.6: Global Skin Microbiome Modulators Market (by Skin Care), 2019-2030
  • Figure 10.1: Global Skin Microbiome Modulators Market (by Distribution Channels)
  • Figure 10.2: Global Skin Microbiome Modulators Market (by Online Channels), 2019-2030
  • Figure 10.3: Global Skin Microbiome Modulators Market (by Hypermarkets and Supermarkets), 2019-2030
  • Figure 10.4: Global Skin Microbiome Modulators Market (by Direct Selling), 2019-2030
  • Figure 10.5: Global Skin Microbiome Modulators Market (by Specialty Store), 2019-2030
  • Figure 10.6: Global Skin Microbiome Modulators Market (by Drug Stores), 2019-2030
  • Figure 11.1: Global Skin Microbiome Modulators Market (by Region), 2019 and 2030
  • Figure 11.2: Global Skin Microbiome Modulators Market (by Region), 2019-2030
  • Figure 11.3: Global Skin Microbiome Modulators Market Share (by Region), 2019
  • Figure 11.4: Global Skin Microbiome Modulators Market Share (by Region), 2030
  • Figure 11.5: North America Skin Microbiome Modulators Market, 2019-2030
  • Figure 11.6: North America: Market Dynamics
  • Figure 11.7: North America Skin Microbiome Modulators Market (by Country), 2019-2030
  • Figure 11.8: U.S. Skin Microbiome Modulators Market, 2019-2030
  • Figure 11.9: Canada Skin Microbiome Modulators Market, 2019-2030
  • Figure 11.10: Europe Skin Microbiome Modulators Market, 2019-2030
  • Figure 11.11: Europe: Market Dynamics
  • Figure 11.12: Europe Skin Microbiome Modulators Market (by Country), 2019-2030
  • Figure 11.13: Germany Skin Microbiome Modulators Market, 2019-2030
  • Figure 11.14: France Skin Microbiome Modulators Market, 2019-2030
  • Figure 11.15: U.K. Skin Microbiome Modulator Market, 2019-2030
  • Figure 11.16: Italy Skin Microbiome Modulators Market, 2019-2030
  • Figure 11.17: Spain Skin Microbiome Modulators Market, 2019-2030
  • Figure 11.18: Rest-of-Europe Skin Microbiome Modulators Market, 2019-2030
  • Figure 11.19: Asia-Pacific Skin Microbiome Modulators Market, 2019-2030
  • Figure 11.20: APAC: Market Dynamics
  • Figure 11.21: APAC Sin Microbiome Modulators Market (by Country), 2019-2030
  • Figure 11.22: Japan Skin Microbiome Modulators Market, 2019-2030
  • Figure 11.23: China Skin Microbiome Modulators Market, 2019-2030
  • Figure 11.24: South Korea Skin Microbiome Modulators Market, 2019-2030
  • Figure 11.25: Australia Skin Microbiome Modulators Market, 2019-2030
  • Figure 11.26: India Skin Microbiome Modulators Market, 2019-2030
  • Figure 11.27: RoAPAC Skin Microbiome Modulators Market, 2019-2030
  • Figure 11.28: Latin America Skin Microbiome Modulators Market, 2019-2030
  • Figure 11.29: Latin America: Market Dynamics
  • Figure 11.30: Latin America Skin Microbiome Modulators Market (by Country), 2019-2030
  • Figure 11.31: Brazil Skin Microbiome Modulators Market, 2019-2030
  • Figure 11.32: Mexico Skin Microbiome Modulators Market, 2019-2030
  • Figure 11.33: Rest-of-Latin America Skin Microbiome Modulators Market, 2019-2030
  • Figure 11.34: RoW Skin Microbiome Modulators Market, 2019-2030
  • Figure 12.1: Total Number of Companies Profiled
  • Figure 12.2: AOBiome (Mother Dirt): Product Portfolio
  • Figure 12.3: AOBiome: Pipeline Products (Drugs)
  • Figure 12.4: AOBiome: SWOT Analysis
  • Figure 12.5: Azitra, Inc.: Pipeline Products
  • Figure 12.6: Azitra, Inc.: SWOT Analysis
  • Figure 12.7: Colgate-Palmolive Company (Tom's of Maine): Product Offerings
  • Figure 12.8. Colgate-Palmolive Company: Overall Financials, 2017-2019
  • Figure 12.9: Colgate-Palmolive Company: Revenue (by Segment), 2017-2019
  • Figure 12.10: Colgate-Palmolive Company.: SWOT Analysis
  • Figure 12.11: Evelo Biosciences, Inc.: Pipeline Products
  • Figure 12.12: Evelo Biosciences, Inc.: SWOT Analysis
  • Figure 12.13: GALLINEE: Product Portfolio
  • Figure 12.14: GALLINEE.: SWOT Analysis
  • Figure 12.15: Glowbiotics, Inc.: Product Portfolio
  • Figure 12.16: Glowbiotics, Inc.: SWOT Analysis
  • Figure 12.17: Johnson and Jonson Services, Inc. (Aveeno): Product Portfolio
  • Figure 12.18: Johnson & Johnson Services, Inc. Company: Overall Financials, 2017-2019
  • Figure 12.19: Johnson & Johnson Services, Inc. Company: R&D Expenditure, 2017-2019
  • Figure 12.20: Johnson & Johnson Services, Inc.: SWOT Analysis
  • Figure 12.21: L'Oreal S.A.: Product Portfolio
  • Figure 12.22: L'Oreal S.A Company: Overall Financials, 2017-2019
  • Figure 12.23: L'Oreal S.A.: SWOT Analysis
  • Figure 12.24: MATRISYS BIOSCIENCE: Pipeline Products Portfolio
  • Figure 12.25: MATRISYS BIOSCIENCE: SWOT Analysis
  • Figure 12.26: Quorum Innovations: Pipeline Product Portfolio
  • Figure 12.27: Quorum Innovations: SWOT Analysis
  • Figure 12.28: Revlon (Elizabeth Arden, Inc.): Product Portfolio
  • Figure 12.29: Revlon: Overall Financials, 2017-2019
  • Figure 12.30: Revlon: Revenue (by Segment), 2017-2019
  • Figure 12.31: Revlon (Elizabeth Arden): Revenue (by Region), 2017-2019
  • Figure 12.32: Revlon: R&D Expenditure, 2017-2019
  • Figure 12.33: Revlon: SWOT Analysis
  • Figure 12.34: Siolta Therapeutics: Product Offerings
  • Figure 12.35: Siolta Therapeutics: SWOT Analysis
  • Figure 12.36: The Estee Lauder Companies, Inc.: Overall Product Portfolio
  • Figure 12.37: The Estee Lauder Companies Inc.: SWOT Analysis
  • Figure 12.38: TULA Life, INC: Product Portfolio
  • Figure 12.39: TULA Life, INC: SWOT Analysis
  • Figure 12.40: Unilever: Product Portfolio
  • Figure 12.41: Unilever: Overall Financials, 2017-2019
  • Figure 12.42: Unilever: Revenue (by Segment), 2017-2019
  • Figure 12.43: Unilever: SWOT Analysis
  • Figure 12.44: Yakult Honsha Co., Ltd.: Product Portfolio
  • Figure 12.45: Yakult Honsha Co., Ltd: Overall Financials, 2017-2019
  • Figure 12.46: Yakult Honsha Co., Ltd: Revenue (by Segment), 2017-2019
  • Figure 12.47: Yakult Honsha Co., Ltd.: SWOT Analysis